Hospital visits, surgeries and long-term care place a heavy burden on our nation’s health care system, and the weight is only projected to increase. In just the next decade, the U.S. will spend $13.5 trillion on hospital care, underscoring the importance of investing in new medicines.
Our new video explains how continued innovation has helped patients to live longer, healthier lives. Shifting the treatment paradigm by slowing, treating and curing diseases has helped patients avoid expensive hospital care. In fact, the Congressional Budget Office has even changed its cost estimating methodology to reflect evidence that increased prescription medicine use in Part D leads to offsetting reductions in Medicare spending for other medical services.
In many cases, research and medicines from the biopharmaceutical sector are the only hope for survival for patients and their families.
- Medicines have helped raise the average U.S. life expectancy from 47 years in 1900 to 78 years.
- Since its peak in 1991, the cancer death rate in the U.S. has fallen 22 percent and 2 of 3 patients diagnosed with cancer live at least 5 years following diagnosis.
- And new hepatitis C therapies have cure rates above 90 percent and dramatically decrease the burden of the disease on the U.S. health care system and the economy.
Medicines can continue to save lives and be part of the solution to reducing medical spending, but only if we have a health care system that supports innovation and encourages the development of new treatments for Alzheimer’s disease and other costly conditions.
Watch our new video to help you learn how medicines can curb health care costs and visit www.phrma.org/cost to learn more.
Get instant updates on issues you care about - here.
Holly Campbell Holly Campbell is a deputy vice president of public affairs at PhRMA focusing on the cost and value of medicines. Prior to joining PhRMA, Holly worked for large and small public relations firms where she provided strategic communications counsel, media relations and partnership expertise to health care and pharmaceutical clients. In her free time, she enjoys taking barre classes, trying new restaurants and spending time with Boss and Poppy, her rescue pups.